SUBACROMIAL INJECTIONS FOR SHOULDER SUBACROMIAL PAIN SYNDROME
Research type
Research Study
Full title
Subacromial injections for shoulder subacromial pain syndrome - comparing anterolateral versus posterior approach. A randomised controlled trial
IRAS ID
249246
Contact name
Helen Spickett
Contact email
Sponsor organisation
Blackpool NHS Foundation Trust
Clinicaltrials.gov Identifier
Duration of Study in the UK
3 years, 0 months, 1 days
Research summary
Patients who present with Shoulder Subacromial Pain Syndrome (disorders such as subacromial bursitis, rotator cuff tendinopathy, calcific tendinitis, subacromial inflammation with a partial thickness rotator cuff tear) to the orthopaedic outpatient clinic are treated initially with a subacromial steroid injection in addition to physiotherapy for a period of 3 months.
The aim of the study is to determine if there is any difference in the effectiveness of a steroid injection, given for Shoulder Subacromial Pain Syndrome, when it is administered via an anterolateral (front) approach as compared to a posterior (back) approach. Here effectiveness is measured in terms of improvement in pain and function.
Patients attending clinic who are diagnosed with Shoulder Subacromial Pain Syndrome, who are 18 years or older, able to give valid consent and able to complete follow up will be invited to participate.
The study will be conducted at Blackpool NHS Foundation Trust. We will be aiming to recruit 86 patients and estimate the total study duration will be 36 months.
Those who agree to participate will be randomly allocated, using sealed envelopes to one of the two approaches for the injection. The injection will then be administered via the selected approach by a clinician who is qualified in carrying out the procedure. Patients will be asked about any discomfort experienced during the injection, improvement in pain following the injection prior to leaving hospital and overall satisfaction with the injection. Following this, patients will have physiotherapy as an outpatient as routine and will be seen at about 3 months following injection for a further assessment at the clinic. Again the shoulder assessment will be repeated on that occasion. Shoulder assessment questionnaires will be posted out for completion at 6 months and 1 year.REC name
North West - Greater Manchester West Research Ethics Committee
REC reference
19/NW/0012
Date of REC Opinion
16 Jan 2019
REC opinion
Favourable Opinion